These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22009194)

  • 41. Measurement of extensive auditory discrimination profiles using the mismatch negativity (MMN) of the auditory event-related potential (ERP).
    Pakarinen S; Takegata R; Rinne T; Huotilainen M; Näätänen R
    Clin Neurophysiol; 2007 Jan; 118(1):177-85. PubMed ID: 17070103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delayed preattentional functioning in early psychosis patients with cannabis use.
    Pesa N; Hermens DF; Battisti RA; Kaur M; Hickie IB; Solowij N
    Psychopharmacology (Berl); 2012 Aug; 222(3):507-18. PubMed ID: 22402706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in mismatch negativity across pre-hypnosis, hypnosis and post-hypnosis conditions distinguish high from low hypnotic susceptibility groups.
    Jamieson GA; Dwivedi P; Gruzelier JH
    Brain Res Bull; 2005 Oct; 67(4):298-303. PubMed ID: 16182937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant temporal behavior of mismatch negativity generators in schizophrenia patients and subjects at clinical high risk for psychosis.
    Kim M; Cho KI; Yoon YB; Lee TY; Kwon JS
    Clin Neurophysiol; 2017 Feb; 128(2):331-339. PubMed ID: 28056388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced mismatch negativity in adolescents with posttraumatic stress disorder (PTSD).
    Ge Y; Wu J; Sun X; Zhang K
    Int J Psychophysiol; 2011 Feb; 79(2):231-5. PubMed ID: 21036193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Forecasting prognostic trajectories with mismatch negativity in early psychosis.
    Kim M; Kim T; Hwang WJ; Lho SK; Moon SY; Lee TY; Kwon JS
    Psychol Med; 2023 Mar; 53(4):1489-1499. PubMed ID: 36315242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mismatch negativity: Alterations in adults from the general population who report subclinical psychotic symptoms.
    Döring C; Müller M; Hagenmuller F; Ajdacic-Gross V; Haker H; Kawohl W; Rössler W; Heekeren K
    Eur Psychiatry; 2016 Apr; 34():9-16. PubMed ID: 26928341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of visual task difficulty and attentional direction on the detection of acoustic change as indexed by the Mismatch Negativity.
    Muller-Gass A; Stelmack RM; Campbell KB
    Brain Res; 2006 Mar; 1078(1):112-30. PubMed ID: 16497283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mismatch negativity (MMN) evoked by sound duration contrasts: an unexpected major effect of deviance direction on amplitudes.
    Colin C; Hoonhorst I; Markessis E; Radeau M; de Tourtchaninoff M; Foucher A; Collet G; Deltenre P
    Clin Neurophysiol; 2009 Jan; 120(1):51-9. PubMed ID: 19028137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The representation of unattended, segmented sounds: a mismatch negativity (MMN) study.
    Weise A; Ritter W; Schröger E
    Int J Psychophysiol; 2011 Aug; 81(2):121-6. PubMed ID: 21600937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mismatch negativity in paranoid, schizotypal, and antisocial personality disorders.
    Liu Y; Shen X; Zhu Y; Xu Y; Cai W; Shen M; Yu R; Wang W
    Neurophysiol Clin; 2007; 37(2):89-96. PubMed ID: 17540291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mismatch negativity subcomponents and ethyl alcohol.
    Jääskeläinen IP; Pekkonen E; Hirvonen J; Sillanaukee P; Näätänen R
    Biol Psychol; 1996 Mar; 43(1):13-25. PubMed ID: 8739611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using Mismatch Negativity to Investigate the Pathophysiology of Substance Use Disorders and Comorbid Psychosis.
    Ramlakhan JU; Zomorrodi R; Downar J; Blumberger DM; Daskalakis ZJ; George TP; Kiang M; Barr MS
    Clin EEG Neurosci; 2018 Jul; 49(4):226-237. PubMed ID: 29502434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review.
    Nagai T; Tada M; Kirihara K; Araki T; Jinde S; Kasai K
    Front Psychiatry; 2013 Sep; 4():115. PubMed ID: 24069006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Event-related potential findings in healthy extremely pre-term (< week 29) children at age 10.
    Lindgren M; Stjernqvist K; Ors M; Rosén I
    Child Neuropsychol; 2000 Jun; 6(2):77-86. PubMed ID: 16210205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does mismatch negativity show differences in reading-disabled children compared to normal children and children with attention deficit?
    Huttunen T; Halonen A; Kaartinen J; Lyytinen H
    Dev Neuropsychol; 2007; 31(3):453-70. PubMed ID: 17559334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Schizophrenic patients are impaired in memory reinstatement underlying mismatch negativity system.
    Minami Y; Kirino E
    Clin Neurophysiol; 2005 Jan; 116(1):120-8. PubMed ID: 15589191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode Psychosis.
    Nagai T; Kirihara K; Tada M; Koshiyama D; Koike S; Suga M; Araki T; Hashimoto K; Kasai K
    Sci Rep; 2017 May; 7(1):2258. PubMed ID: 28536477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose-related effects of memantine on a mismatch negativity-like response in anesthetized rats.
    Tikhonravov D; Neuvonen T; Pertovaara A; Savioja K; Ruusuvirta T; Näätänen R; Carlson S
    Neuroscience; 2010 Jun; 167(4):1175-82. PubMed ID: 20298759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.